Wednesday, 21 August 2019

Pharma News

  • Who will wear the CSL mantle?

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: Current president of CSL Behring, Mr Paul Perreault, will be the new CEO of the firm after Dr Brian McNamee steps down in July 2013. Dr Brian McNamee will leave CSL in July 2013 ...Read more

  • AstraZeneca's CFO quits to join BG Group

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: AstraZeneca's chief financial officer Mr Simon Lowth is going to quit the company to join in the same role at BG Group. Mr Lowth, 51, will address the challenges that the BG Grou...Read more

  • Novartis under fire from Tasigna allegations

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

    Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigation under possible violation of the pharmaceutical affairs law. It has...Read more

  • Golden Meditech's revenue increases by 6%

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Golden Meditech Holdings, a leading integrated healthcare enterprise in China, announced the group's interim results for the six months ended 30 September 2012.  During the in...Read more

  • Ranbaxy reflects on steps taken for product safety

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

    Singapore: Ranbaxy Laboratories highlighted some of the major specific actions the company has been taking in recent years to address certain conduct of the past and to ensure the safety an...Read more

  • Regeneron acquires Sanofi eye care antibodies

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 May, 2013

    Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from Sanofi. Regeneron acquired full rights to antibodies targeting the PDGF ...Read more

  • Daiichi seeks approval for influenza antiviral in Japan

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the influenza antiviral product Inavir Dry Powder Inhaler (laninamivir o...Read more

  • Teva, Xenon enter $335 mn deal for pain drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative development and exclusive worldwide license for XEN402. XEN402 is curre...Read more

  • Dong-A Pharma appoints new co-CEO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    Singapore: Korea-based Dong-A Pharmaceutical has appointed Mr Lee Dong Hun as its new co-chief executive officer. He would be replacing Mr Kim Won Bae, effective March 4, 2013. The current ...Read more

  • Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (teneligliptin hydrobromide hydrate tablets) in Japan on September 10, 2012...Read more

  • Alzheimer's Association calls for early detection

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: Alzheimer's Association, US, is making efforts to improve early detection and diagnosis of Alzheimer's disease and increase the use of information and support services. The vario...Read more

  • China to expand list of price-controlled drugs

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Singapore: China is set to increase the number of products on its price-controlled "essential drugs" list. Report from Reuters and the official Shanghai Securities Journal reported that the...Read more

  • Lilly cancer drug patent gets US court nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The US Court of Appeals for the Federal Circuit has affirmed a prior ruling by the US District Court for the District of Delaware that Eli Lilly's compound patent for Alimta (pem...Read more

  • Bangalore gets medical quality assesment lab

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: CSA Group, global testing and certification service provider with operations in China, has launched a testing and certification laboratory in Bangalore, India. The new laborator...Read more

  • AseaCyte gets BioSpectrum award for drug discovery efforts

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit cancer research institute in Malaysia; and Dr...Read more

  • Sinopharm to build China's largest R&D center

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: Sinopharm Group is going to build China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone. The facility will showcase all of Sinopharm's existing biote...Read more

  • Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...Read more

  • Roche gives up its patent battle in India

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Roche will not pursue patent application for its breast cancer drug Herceptin in India. However, Roche said that it would continue to enforce other patents covering its drugs in ...Read more



Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls